Abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged as a virus with a pathogenicity closer to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and a transmissibility similar to common cold coronaviruses (CoVs). In this review, we briefly discuss the features of the receptor-binding domain (RBD) and protease cleavage of the SARS-CoV-2 spike protein that enable SARS-CoV-2 to be a pandemic virus.
Funding Information
  • National Institute of Allergy and Infectious Diseases (AI153602)
  • National Institute on Aging (AG049042)
  • National Institute of Allergy and Infectious Diseases (R24AI120942)

This publication has 38 references indexed in Scilit: